NINGBO INNO PHARMCHEM CO.,LTD. is a leading supplier of critical chemical intermediates, and (2S)-2-Aminopentanoic Acid (CAS 6600-40-4) is a prominent example of our commitment to the pharmaceutical industry. This compound, widely recognized as L-Norvaline, serves as a fundamental building block in the intricate processes of creating both nutritive agents and essential medicines. Its consistent purity and reliable performance make it an indispensable component for businesses focused on health and therapeutic innovation.

The specifications of 2-aminopentanoic acid CAS 6600-40-4 are well-documented: it is a white fine crystalline powder with a molecular formula of C5H11NO2 and a molecular weight of 117.146. Its stability under typical storage conditions and its relatively high melting point of 300°C ensure that it can be safely handled and utilized in various synthetic pathways. These inherent physical and chemical properties are crucial for its function as a pharmaceutical intermediate, where reproducibility and predictability are paramount for successful outcomes.

The primary applications for (2S)-2-Aminopentanoic Acid lie in the synthesis of nutritive agents and medicines. In the realm of nutrition, it contributes to the development of supplements designed to enhance physiological functions or provide essential amino acid building blocks. In pharmaceutical manufacturing, this L-Norvaline pharmaceutical intermediate is employed in the multi-step synthesis of active pharmaceutical ingredients (APIs) for a range of therapeutic areas. The meticulous nature of drug synthesis requires intermediates that meet stringent quality standards, a requirement that this compound reliably fulfills.

For companies seeking to innovate in the health and wellness sector, securing a dependable supply of key intermediates like (2S)-2-Aminopentanoic Acid is a strategic imperative. NINGBO INNO PHARMCHEM CO.,LTD. ensures that our clients have access to this vital chemical, supporting their research and development efforts and their production pipelines. By providing this high-quality pharmaceutical intermediate, we aim to facilitate advancements in medicine and nutrition, contributing to improved global health outcomes.